ACTON, Mass. (AP) _ Insulet Corp. (PODD) on Thursday reported second-quarter profit of $14.4 million.

On a per-share basis, the Acton, Massachusetts-based company said it had profit of 22 cents.

The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.

The maker of insulin infusion systems posted revenue of $226.3 million in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $211.9 million.

Insulet shares have climbed 28% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $219.97, an increase of 54% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD

Automated Insights, source Associated Press News